These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3971844)

  • 21. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.
    Perriello G; De Feo P; Torlone E; Fanelli C; Santeusanio F; Brunetti P; Bolli GB
    Diabetologia; 1990 Jan; 33(1):52-9. PubMed ID: 2406181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
    Wentholt IM; Maran A; Masurel N; Heine RJ; Hoekstra JB; DeVries JH
    Diabet Med; 2007 May; 24(5):527-32. PubMed ID: 17381503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preprandial blood glucose values and glycemic responses in insulin-dependent diabetes mellitus at constant insulinemia.
    Rasmussen O; Hermansen K
    Am J Clin Nutr; 1991 Feb; 53(2):520-3. PubMed ID: 1989420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic continuous intraperitoneal insulin infusion (CIPII) in type I diabetic patients non-satisfactorily responsive to continuous subcutaneous insulin infusion (CSII).
    Micossi P; Bosi E; Cristallo M; Monti LD; Librenti MC; Petrella G; Galimberti G; Spotti D; Giudici G; Vergani C
    Acta Diabetol Lat; 1986; 23(2):155-64. PubMed ID: 3751449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
    Tuttle KR; Bruton JL; Perusek MC; Lancaster JL; Kopp DT; DeFronzo RA
    N Engl J Med; 1991 Jun; 324(23):1626-32. PubMed ID: 2030719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
    Choudhary P; Davies C; Emery CJ; Heller SR
    Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
    Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
    Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nocturnal continuous subcutaneous insulin infusion--a therapeutic possibility in labile type I diabetes under exceptional conditions].
    Bruns W; Steinborn F; Menzel R; Staritz B; Bibergeil H
    Z Gesamte Inn Med; 1990 Mar; 45(6):154-8. PubMed ID: 2197828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
    Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.
    Beaufrère B; Beylot M; Metz C; Ruitton A; François R; Riou JP; Mornex R
    Diabetologia; 1988 Aug; 31(8):607-11. PubMed ID: 3065115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of insulin antibodies on metabolic deterioration after interruption of continuous subcutaneous insulin infusion.
    Montaña E; Fernández-Castañer M; Rosel P; Gómez JM; Vinzia C; Soler J
    Diabete Metab; 1990; 16(3):220-5. PubMed ID: 2210017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of nocturnal hypoglycemia to cause fasting hyperglycemia in patients with insulin-dependent diabetes mellitus.
    Tordjman KM; Havlin CE; Levandoski LA; White NH; Santiago JV; Cryer PE
    N Engl J Med; 1987 Dec; 317(25):1552-9. PubMed ID: 3317053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII.
    Lawson P; Home PD; Bergenstal R
    Diabetes; 1985 Aug; 34 Suppl 3():27-30. PubMed ID: 3894126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of insulin sensitivity on the occurrence of early-morning hyperglycemia in patients treated with insulin].
    Krzymień J; Szymerska E; Tracz M; Regulski M; Jasik M
    Pol Arch Med Wewn; 1989 Mar; 81(3):176-82. PubMed ID: 2697868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.
    Zisser HC; Bevier WC; Jovanovic L
    Diabetes Technol Ther; 2007 Dec; 9(6):509-15. PubMed ID: 18034605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dawn phenomenon revisited: implications for diabetes therapy.
    Carroll MF; Schade DS
    Endocr Pract; 2005; 11(1):55-64. PubMed ID: 16033737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy.
    Carroll MF; Hardy KJ; Burge MR; Schade DS
    Diabetes Technol Ther; 2002; 4(5):595-605. PubMed ID: 12450440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.